SOUTHWEST ONCOLOGY GROUP TRIAL S9912: INTRAPERITONEAL CISPLATIN AND PACLITAXEL PLUS INTRAVENOUS PACLITAXEL AND PEGYLATED LIPOSOMAL DOXORUBICIN AS PRIMARY CHEMOTHERAPY OF SMALL-VOLUME RESIDUAL STAGE III OVARIAN CANCER

OBJECTIVE: While primary cisplatin-based intraperitoneal chemotherapy has been shown to favorably impact survival in small-volume residual advanced ovarian cancer, there is a need to develop strategies that improve the effectiveness of this approach. METHODS: A multi-center phase 2 trial was conduct...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Smith, Harriet O., Moon, James, Wilczynski, Sharon P., Tiersten, Amy D., Hannigan, Edward V., Robinson, William R., Rivkin, Saul E., Anderson, Garnet L., Liu, P.Y., Markman, Maurie
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2703693/
https://ncbi.nlm.nih.gov/pubmed/19464730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2009.04.023
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares